Inventor · disambiguated record
Lisa Purcell
Also filed as: PURCELL LISA · PURCELL LISA A · PURCELL LISA ARLEEN
16 granted patents·5 pending applications·18 citations·filing 2015–2024
89Inventor score
Files withREGENERON PHARMA21
Top patents by PatentIndex Score
21 records- 0192US10070632B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2017·Granted Sep 11, 2018·5 cites·23 claims
- 0291US10070631B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2017·Granted Sep 11, 2018·4 cites·22 claims
- 0387US10314904B2Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonistREGENERON PHARMA·Filed 2017·Granted Jun 11, 2019·5 cites·21 claims
- 0483US2024147971A1Rodents having a humanized tmprss geneREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0582US12091449B2Anti-PfRH5 antibodies and antigen-binding fragments thereofREGENERON PHARMA·Filed 2023·Granted Sep 17, 2024·0 cites·11 claims
- 0681US11453714B2Human antibodies to influenza hemagglutininREGENERON PHARMA·Filed 2020·Granted Sep 27, 2022·1 cites·35 claims
- 0781US2024400663A1Anti-PfRH5 Antibodies and Antigen-Binding Fragments ThereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0880US12065506B2Anti-TMPRSS2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2023·Granted Aug 20, 2024·0 cites·31 claims
- 0980US11667701B2Anti-PfRH5 antibodies and antigen-binding fragments thereofREGENERON PHARMA·Filed 2019·Granted Jun 6, 2023·1 cites·11 claims
- 1078US10689436B2Human antibodies to influenza hemagglutininREGENERON PHARMA·Filed 2019·Granted Jun 23, 2020·1 cites·17 claims
- 1178US2024082380A1Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R AntagonistREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1274US2024343831A1Anti-tmprss2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1372US11910787B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2020·Granted Feb 27, 2024·0 cites·21 claims
- 1471US11603413B2Anti-TMPRSS2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2021·Granted Mar 14, 2023·0 cites·20 claims
- 1570US10863729B2Rodents having a humanized TMPRSS geneREGENERON PHARMA·Filed 2018·Granted Dec 15, 2020·0 cites·16 claims
- 1669US10392432B2Human antibodies to influenza hemagglutininREGENERON PHARMA·Filed 2015·Granted Aug 27, 2019·1 cites·16 claims
- 1767US11999799B2Anti-TMPRSS2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2021·Granted Jun 4, 2024·0 cites·44 claims
- 1867US10941213B2Anti-TMPRSS2 antibodies and antigen-binding fragmentsREGENERON PHARMA·Filed 2019·Granted Mar 9, 2021·0 cites·22 claims
- 1962US10525106B2Angiopoietin-based interventions for treating cerebral malariaREGENERON PHARMA·Filed 2019·Granted Jan 7, 2020·0 cites·13 claims
- 2058US2019321457A1Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R AntagonistREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 2146US11780907B2Human antibodies to influenza hemagglutininREGENERON PHARMA·Filed 2019·Granted Oct 10, 2023·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Lisa Purcell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →